Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

167 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness

NCT01591551

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • South Shore Neurologic Associates Patchogue, New York, United States
  • Cornerstone Neurology High Point, North Carolina, United States
  • Providence Brain Institute Portland, Oregon, United States
View Trial Details
Completed

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®

NCT01075880

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Neurologicka klinika FNBB Brno, Czechia
  • Neurologicka klinika, Fakultní nemocnice U Sv. Anny Brno, Czechia
  • Neurologicke oddeleni KN. České Budějovice, Czechia
  • Neurologicka klinika Fakultní nemocnice Hradec Králové, Czechia
View all 13 locations
View Trial Details
Completed

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

NCT00461396

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Many Locations, Alabama, United States
  • Many Locations, Arizona, United States
  • Many Locations, Delaware, United States
  • Many Locations, District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

NCT01158183

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Many Locations, Alabama, United States
  • Many Locations, California, United States
  • Many Locations, Colorado, United States
  • Many Locations, Florida, United States
View all 27 locations
View Trial Details

Related conditions